Rhythm Pharmaceuticals
Price & Volume
Stats
See more52W Range | $45.90-$116 |
Market Cap | $7.1B |
Shares Short | 5M |
Financials
See moreRevenue (12 Mos) | $174.3M |
Revenue Growth (YoY) | 54.3% |
Gross Profit (12 Mos) | $155.8M |
Diluted EPS | -$3.10 |
News
See moreYahoo Finance • 4 days ago
Brinker upgraded, Coinbase downgraded: Wall Street's top analyst calls
Yahoo Finance • 4 days ago
Rhythm Pharmaceuticals initiated with Buy at Citi on Imcivree's potential
Yahoo Finance • 22 days ago
Rhythm pharma down as FDA extends review period for Imcivree label expansion
About
CEO | Dr. David P. Meeker M.D. |
CFO | Mr. Hunter C. Smith M.B.A. |
Address | 222 Berkeley Street, Boston, MA, United States, 02116 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 283 |
